Warner-Lambert
Executive Summary
In preparation for impending retirement of Exec VP Donald O'Neill, company made series of organization moves: Parke-Davis President Joseph Smith and International Operations President John Walsh promoted to exec VPs; Lodewijk de Vink, exec VP and president of U.S. operations, will succeed O'Neill as chairman of the pharmaceutical review board. Novon Products President Philip Gross will report to President and Chief Operating Officer Mel Goodes.